查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1595309

醫藥 B2B 電子商務市場：經營模式、產品類型、治療領域、經銷類型 - 2025-2030 年全球預測

Pharma B2B eCommerce Market by Business Model (B2B2B, B2B2C), Product Type (Over-the-Counter (OTC) Products, Prescription Drugs), Therapeutic Area, Distribution Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年醫藥B2B電商市場規模為281.1億美元，預計2024年將達302.3億美元，複合年成長率為7.70%，預計2030年將達472.7億美元。

醫藥B2B電子商務市場範圍涵蓋醫藥產品的數位化購買和銷售，特別是醫院、診所、藥局和經銷商等企業。隨著數位轉型的發展，這項市場需求源自於簡化採購流程、提高成本效率和提高供應鏈透明度的需求。該領域的應用包括用於直接訂購的數位平台、庫存管理系統和增強的供應商協作。最終用途主要是醫療保健提供者、藥品製造商和研究機構。主要成長要素包括醫療保健數位化的提高、慢性病數量迅速增加對醫藥中間體的需求增加，以及需要有效追蹤和監控藥品交易的監管合規性的提高。潛在的機會在於人工智慧 (AI) 支援的預測分析、透過先進的數位介面改善用戶體驗以及透過全球線上平台擴大覆蓋範圍。鼓勵企業投資擴充性的電子商務解決方案以實現未來成長，遵守資料安全措施，並採用多通路參與策略來提高客戶滿意度。然而，嚴格的政府監管、網路安全風險和高昂的初始投資成本等限制和挑戰構成了主要障礙。此外，傳統採購方法的變革阻力和資料整合的複雜性是常見的障礙。研究和開發應專注於開發強大的區塊鏈系統以確保交易透明度和安全性、用於客戶協助的基於人工智慧的聊天機器人以及用於即時庫存管理的物聯網應用程式。市場是充滿活力的，並因技術進步和監管變化而蓬勃發展，因此持續監控和適應這些變化以維持業務成功和競爭力非常重要。最終，醫藥B2B電子商務的發展能力將取決於其有效應對這些挑戰、最佳化供應鏈以及利用未來新技術趨勢的能力。

主要市場統計
基準年[2023] 281.1億美元
預測年份 [2024] 302.3億美元
預測年份 [2030] 472.7億美元
複合年成長率（%） 7.70%

市場動態：揭示快速發展的醫藥 B2B 電子商務市場的關鍵市場洞察

供需的動態交互作用正在改變醫藥 B2B 電子商務市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 藥局與醫療機構數位轉型介紹
    • 採購管理改善採購流程並減少複雜的運輸處理
    • 維持監管控制和可追溯性的需要
  • 市場限制因素
    • 電子商務平台與現有系統的複雜整合
  • 市場機會
    • 在開發個人化方法和改善客戶體驗方面快速成長
    • 加大投入提升醫藥B2B電商平台營運效率
  • 市場挑戰
    • 仿冒品和品質問題

波特五力：駕馭醫藥 B2B 電子商務市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解醫藥B2B電子商務市場的外部影響

外部宏觀環境因素對於塑造醫藥B2B電商市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解醫藥B2B電商市場競爭態勢

醫藥 B2B 電子商務市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 醫藥 B2B 電子商務市場定位矩陣供應商績效評估

FPNV定位矩陣是評估醫藥B2B電子商務市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製 B2B 電子商務市場的成功之路

醫藥 B2B 電子商務市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 推動藥房和醫療保健提供者的數位轉型
      • 採購管理改善了採購流程並降低了運輸流程的複雜性。
      • 需要維持目錄有限的藥品的監管控制和可追溯性。
    • 抑制因素
      • 電商平台與現有系統的複雜整合
    • 機會
      • 在開發個人化方法和改善客戶體驗方面快速成長
      • 加大投入提升醫藥B2B電商平台營運效率
    • 任務
      • 藥品假冒和品質問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 醫藥B2B電子商務市場：依經營模式

  • B2B2B
  • B2B2C

第7章 醫藥B2B電子商務市場：依產品類型

  • 非處方藥 (OTC)
  • 處方藥
    • 糖尿病管理
    • 專門護理
    • 疫苗

第8章依治療領域分類的醫藥B2B電子商務市場

  • 心血管
  • 皮膚科
  • 胃腸病學
  • 感染疾病
  • 神經病學
  • 腫瘤學
  • 呼吸系統

第9章以配送類型分類的醫藥B2B電子商務市場

  • 由經銷商/批發商擁有的數位電子商務
  • 藥品製造商自有的數位電子商務

第10章 美洲醫藥B2B電商市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太醫藥B2B電子商務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東、非洲醫藥B2B電商市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Udaan 宣佈為藥局提供“4x4 送貨服務”
    • Saveo 籌集 450 萬美元以簡化 B2B 藥品供應鏈
    • 亞洲醫療保健集團開發關鍵高科技平台來戰勝 COVID-19
  • 戰略分析和建議

公司名單

  • Amazon.com, Inc.
  • AmerisourceBergen Corporation
  • Ayro Retail Solutions Pvt. Ltd
  • Becton, Dickinson & Company
  • Biddano Pvt Ltd.
  • Cardinal Health, Inc.
  • Cloudfy Ltd.
  • Corevist, Inc.
  • Divante SA
  • Entersoft SA
  • Eurofins Scientific
  • EuroPlux
  • GXgate
  • Henry Schein, Inc.
  • hystrix medical AG
  • Invertus
  • Mckesson Corporation
  • Medcombo by Behmpat Producciones SL
  • Medideals Resources LLP
  • Merck KGaA
  • Ochre Media Pvt Ltd
  • Oro, Inc.
  • Pharma Vends by Hivends Info Solutions Pvt. Ltd
  • Pharmaflair
  • Pharmaoffer
  • PHARMATRADZ
  • Piegon Media Pvt. Ltd.
  • PipelinePharma
  • Remedial Health Solutions Limited
  • Sandoz by Novartis AG
  • Thermo Fisher Scientific, Inc.
  • TrueCommerce Inc.
  • Trxade, Health Inc.
  • Wizarma Healthcare Private Limited
  • Yaoshibang
Product Code: MRR-2F11EB639CB7

The Pharma B2B eCommerce Market was valued at USD 28.11 billion in 2023, expected to reach USD 30.23 billion in 2024, and is projected to grow at a CAGR of 7.70%, to USD 47.27 billion by 2030.

The Pharma B2B eCommerce market scope encompasses the digital buying and selling of pharmaceutical products, especially targeting businesses such as hospitals, clinics, pharmacies, and distributors. With the increasing digital shift, the necessity for this market stems from the need for streamlined procurement processes, cost efficiencies, and enhanced supply chain transparency. Applications within this domain include digital platforms for direct ordering, inventory management systems, and enhanced vendor collaboration. End-use scope primarily revolves around serving healthcare providers, pharmaceutical manufacturers, and research institutions. Key growth influencers include the rise in healthcare digitization, growing demand for pharmaceutical intermediates due to the proliferation of chronic diseases, and an increase in regulatory compliances that necessitate efficient tracking and monitoring of pharmaceutical transactions. Potential opportunities lie in leveraging Artificial Intelligence (AI) for predictive analytics, enhancing user experience with advanced digital interfaces, and expanding reach through global online platforms. Companies are recommended to invest in scalable eCommerce solutions that accommodate future growth, adhere to data security measures, and incorporate multi-channel engagement strategies to heighten customer satisfaction. However, limitations and challenges such as stringent governmental regulations, cybersecurity risks, and high initial investment costs pose significant hurdles. Moreover, resistance to change from traditional procurement methods and data integration complexities are prevalent barriers. Innovation and research should focus on developing robust blockchain systems for transparency and security in transactions, AI-based chatbots for customer assistance, and IoT applications for real-time inventory management. The market is dynamic, thriving on technological advancements and regulatory shifts, so consistent monitoring and adaptation to these changes will be crucial for sustained business success and competitiveness. Ultimately, the forward momentum of Pharma B2B eCommerce hinges on effectively addressing these challenges and capitalizing on emerging technology trends to optimize and future-proof supply chains.

KEY MARKET STATISTICS
Base Year [2023] USD 28.11 billion
Estimated Year [2024] USD 30.23 billion
Forecast Year [2030] USD 47.27 billion
CAGR (%) 7.70%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharma B2B eCommerce Market

The Pharma B2B eCommerce Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Embracing digital transformation in pharmacies and healthcare providers
    • Improve the procurement process with purchase controls and reduce the complexity of carriage handling
    • Need to maintain regulatory control and traceability in pharma with restricted catalogs
  • Market Restraints
    • Complex integration of eCommerce platforms with the existing systems
  • Market Opportunities
    • Rapid growth in developing personalized approaches and improving the customer experiences
    • Increasing investment to improve the operational efficiencies of pharma B2B eCommerce platforms
  • Market Challenges
    • Issues associated with the counterfeit and quality concerns of the pharma products

Porter's Five Forces: A Strategic Tool for Navigating the Pharma B2B eCommerce Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharma B2B eCommerce Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharma B2B eCommerce Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharma B2B eCommerce Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharma B2B eCommerce Market

A detailed market share analysis in the Pharma B2B eCommerce Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharma B2B eCommerce Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharma B2B eCommerce Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharma B2B eCommerce Market

A strategic analysis of the Pharma B2B eCommerce Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharma B2B eCommerce Market, highlighting leading vendors and their innovative profiles. These include Amazon.com, Inc., AmerisourceBergen Corporation, Ayro Retail Solutions Pvt. Ltd, Becton, Dickinson & Company, Biddano Pvt Ltd., Cardinal Health, Inc., Cloudfy Ltd., Corevist, Inc., Divante S.A., Entersoft SA, Eurofins Scientific, EuroPlux, GXgate, Henry Schein, Inc., hystrix medical AG, Invertus, Mckesson Corporation, Medcombo by Behmpat Producciones S.L, Medideals Resources LLP, Merck KGaA, Ochre Media Pvt Ltd, Oro, Inc., Pharma Vends by Hivends Info Solutions Pvt. Ltd, Pharmaflair, Pharmaoffer, PHARMATRADZ, Piegon Media Pvt. Ltd., PipelinePharma, Remedial Health Solutions Limited, Sandoz by Novartis AG, Thermo Fisher Scientific, Inc., TrueCommerce Inc., Trxade, Health Inc., Wizarma Healthcare Private Limited, and Yaoshibang.

Market Segmentation & Coverage

This research report categorizes the Pharma B2B eCommerce Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Business Model, market is studied across B2B2B and B2B2C.
  • Based on Product Type, market is studied across Over-the-Counter (OTC) Products and Prescription Drugs. The Prescription Drugs is further studied across Diabetes Management, Specialty Care, and Vaccines.
  • Based on Therapeutic Area, market is studied across Cardiovascular, Dermatology, Gastroenterology, Infectious Diseases, Neurology, Oncology, and Respiratory.
  • Based on Distribution Type, market is studied across Distributor/Wholesaler-Owned Digital eCommerce and Pharmaceutical Manufacturer-Owned Digital eCommerce.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Embracing digital transformation in pharmacies and healthcare providers
      • 5.1.1.2. Improve the procurement process with purchase controls and reduce the complexity of carriage handling
      • 5.1.1.3. Need to maintain regulatory control and traceability in pharma with restricted catalogs
    • 5.1.2. Restraints
      • 5.1.2.1. Complex integration of eCommerce platforms with the existing systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid growth in developing personalized approaches and improving the customer experiences
      • 5.1.3.2. Increasing investment to improve the operational efficiencies of pharma B2B eCommerce platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Issues associated with the counterfeit and quality concerns of the pharma products
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharma B2B eCommerce Market, by Business Model

  • 6.1. Introduction
  • 6.2. B2B2B
  • 6.3. B2B2C

7. Pharma B2B eCommerce Market, by Product Type

  • 7.1. Introduction
  • 7.2. Over-the-Counter (OTC) Products
  • 7.3. Prescription Drugs
    • 7.3.1. Diabetes Management
    • 7.3.2. Specialty Care
    • 7.3.3. Vaccines

8. Pharma B2B eCommerce Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Cardiovascular
  • 8.3. Dermatology
  • 8.4. Gastroenterology
  • 8.5. Infectious Diseases
  • 8.6. Neurology
  • 8.7. Oncology
  • 8.8. Respiratory

9. Pharma B2B eCommerce Market, by Distribution Type

  • 9.1. Introduction
  • 9.2. Distributor/Wholesaler-Owned Digital eCommerce
  • 9.3. Pharmaceutical Manufacturer-Owned Digital eCommerce

10. Americas Pharma B2B eCommerce Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pharma B2B eCommerce Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pharma B2B eCommerce Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Udaan Announces '4x4 Delivery Service' For Pharmacies
    • 13.3.2. Saveo Raises USD 4.5 Mn To Streamline B2B Pharma Supply Chain
    • 13.3.3. Asian Healthcare Group Develops Vital High-Tech Platform, Beating Back COVID-19
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amazon.com, Inc.
  • 2. AmerisourceBergen Corporation
  • 3. Ayro Retail Solutions Pvt. Ltd
  • 4. Becton, Dickinson & Company
  • 5. Biddano Pvt Ltd.
  • 6. Cardinal Health, Inc.
  • 7. Cloudfy Ltd.
  • 8. Corevist, Inc.
  • 9. Divante S.A.
  • 10. Entersoft SA
  • 11. Eurofins Scientific
  • 12. EuroPlux
  • 13. GXgate
  • 14. Henry Schein, Inc.
  • 15. hystrix medical AG
  • 16. Invertus
  • 17. Mckesson Corporation
  • 18. Medcombo by Behmpat Producciones S.L
  • 19. Medideals Resources LLP
  • 20. Merck KGaA
  • 21. Ochre Media Pvt Ltd
  • 22. Oro, Inc.
  • 23. Pharma Vends by Hivends Info Solutions Pvt. Ltd
  • 24. Pharmaflair
  • 25. Pharmaoffer
  • 26. PHARMATRADZ
  • 27. Piegon Media Pvt. Ltd.
  • 28. PipelinePharma
  • 29. Remedial Health Solutions Limited
  • 30. Sandoz by Novartis AG
  • 31. Thermo Fisher Scientific, Inc.
  • 32. TrueCommerce Inc.
  • 33. Trxade, Health Inc.
  • 34. Wizarma Healthcare Private Limited
  • 35. Yaoshibang

LIST OF FIGURES

  • FIGURE 1. PHARMA B2B ECOMMERCE MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMA B2B ECOMMERCE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PHARMA B2B ECOMMERCE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PHARMA B2B ECOMMERCE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMA B2B ECOMMERCE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMA B2B ECOMMERCE MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY B2B2B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY B2B2C, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY SPECIALTY CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTOR/WHOLESALER-OWNED DIGITAL ECOMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURER-OWNED DIGITAL ECOMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. PHARMA B2B ECOMMERCE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. PHARMA B2B ECOMMERCE MARKET, FPNV POSITIONING MATRIX, 2023